FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
NCT04453540 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2020-07-01
Summary
The research aims to determine the impact of a syndromic mutiplex PCR assay (FilmArray) on the management of patients hospitalized in ICU for severe respiratory disease.
During the SARS-CoV-2 outbreak, the diagnosis of pneumonia has become considerably more complex as the biological, radiological and clinical criteria of covid-19 interfere with the standard criteria for the diagnosis of severe respiratory diseases. Moreover, patients with COVID-19 are at higher risk of developing other associated infections and thus, patients have therefore often been treated with antibiotics, adequately or not, due to difficulty to quickly identify the etiology of their symptoms with conventional methods.
In order to improve their treatment, both diagnostic and therapeutic, we set up a new syndromic molecular test in our laboratories to accelerate and improve the pneumonia management and antibiotic stewardship. This research will include 100 to 150 adult patients hospitalized in ICU during the first half of 2020. It will take place within the Nancy University Hospital and the Reims University Hospital, France.
Conditions
- Infectious Disease
- Pneumonia
- Molecular Diagnosis
- Covid-19
- Antibiotic Stewardship
Interventions
- DIAGNOSTIC_TEST
-
FilmArray PCR on respiratory samples
Molecular test performed on respiratory samples realized for microbiological routine testing as part of the care
Sponsors & Collaborators
-
Reims University hospital
collaborator OTHER -
Central Hospital, Nancy, France
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2020-08-30
- Completion
- 2020-08-30
More Related Trials
-
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
NCT06349707 ·Status: COMPLETED
-
Lung Bacteriobiota and Influenza Mortality
NCT04131296 ·Status: UNKNOWN
-
Role of Multiplex PCR in CAP
NCT06097117 ·Status: NOT_YET_RECRUITING
-
Impact of a Regional Antimicrobial Stewardship on the Length of Stay of Patients Admitted to Hospital With Pneumonia
NCT02276092 ·Status: COMPLETED
-
Co-infection Management in COVID-19 Critically Ill
NCT04382092 ·Status: COMPLETED ·Phase: NA
-
Point-of-Care Multiplex for Adult Patients With Severe Community-acquired Pneumonia
NCT04835818 ·Status: UNKNOWN ·Phase: NA
-
Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia
NCT05937126 ·Status: COMPLETED
-
Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia
NCT04422613 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19
NCT04376840 ·Status: COMPLETED ·Phase: NA
-
The Clinical Value of FA in AHLRI Patients
NCT03391076 ·Status: UNKNOWN ·Phase: NA
-
RAPid SOlution for Diagnosis of Respiratory Infection in Pediatric Intensive Care Unit
NCT04773704 ·Status: COMPLETED
-
FilmArray Pneumonia Panel for Antimicrobial Treatment of HAP/VAP in Intensive Care Units
NCT05214716 ·Status: TERMINATED ·Phase: NA
-
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures
NCT06916481 ·Status: RECRUITING
-
Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study
NCT04365764 ·Status: COMPLETED
-
Long-term Pulmonary Outcomes After Infection With Sars-CoV-2
NCT04401163 ·Status: COMPLETED
-
Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room
NCT05657275 ·Status: COMPLETED ·Phase: NA
-
Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.
NCT04077697 ·Status: COMPLETED
-
Immune Changes in Severe COVID-19 Pulmonary Infections
NCT04386395 ·Status: COMPLETED
-
Influenza Associated Aspergillosis In-depth Investigation
NCT03748069 ·Status: RECRUITING
-
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
NCT04955756 ·Status: UNKNOWN ·Phase: NA
-
Pulmonary Microbiota in Patients With Chronic Obstructive Pulmonary Disease Colonized With P. Aeruginosa Resistant to Imipenem
NCT03008746 ·Status: COMPLETED ·Phase: NA
-
Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients
NCT04674410 ·Status: WITHDRAWN
-
Second-generation Sequencing Guides the Treatment of Severe Pneumonia
NCT03884881 ·Status: UNKNOWN ·Phase: NA
-
Drug Resistance Factors In Healthcare-associated Pneumonia
NCT02736097 ·Status: COMPLETED
-
Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia
NCT05606627 ·Status: UNKNOWN